COMP <GO>
ATOS vs IMMP // RETURN ON INVESTED CAPITAL (ROIC)
Atossa Therapeutics Inc. (NASDAQ) VS. Immutep Limited (NASDAQ) • 15-METRIC TALLY: ATOS 1
— IMMP 1
■ METRIC PARITY
LAST: $2.23 (-5.91%) • MKT CAP: $22.3M
roic
-35.00%
LAST: $3.33 (+0.30%) • MKT CAP: $24.5M
roic
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ATOS VS. IMMP)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ATOS | IMMP | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | -35.00% | — | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | — | — | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 40.3 | 23.1 | +17.15 | ATOS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $22.3M | $24.5M | -$2.3M | IMMP | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ATOS REV | IMMP REV | ATOS GROSS % | IMMP GROSS % | ATOS FCF | IMMP FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | — | — | — | -$29.8M | — |
| FY 2024 | $0 | — | — | — | -$21.0M | — |
| FY 2023 | $0 | — | — | — | -$20.9M | — |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ATOS // BETA —
IMMP // BETA —